Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 12;16(3):5830-8.
doi: 10.3390/ijms16035830.

A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility

Cinzia Ciccacci  1 , Sara Rufini  2 , Sandro Mancinelli  3 , Ersilia Buonomo  4 , Emiliano Giardina  5   6 , Paola Scarcella  7 , Maria C Marazzi  8 , Giuseppe Novelli  9 , Leonardo Palombi  10 , Paola Borgiani  11
Affiliations

A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility

Cinzia Ciccacci et al. Int J Mol Sci. .

Abstract

Steven-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe adverse drug reactions, characterized by extensive epidermal detachment and erosions of mucous membrane. SJS/TEN is one of the most serious adverse reactions to Nevirapine (NVP) treatment, commonly used in developing countries as first-line treatment of human immunodeficiency virus infection. In the last years TRAF3IP2 gene variants had been described as associated with susceptibility to several diseases such as psoriasis and psoriatic arthritis. We hypothesized that this gene, involved in immune response and in NF-κB activation, could also be implicated in the SJS/TEN susceptibility. We performed a full resequencing of TRAF3IP2 gene in a population of patients treated with NVP. Twenty-seven patients with NVP-induced SJS/TEN and 78 controls, all from Mozambique, were enrolled. We identified eight exonic and three intronic already described variants. The case/control association analysis highlighted an association between the rs76228616 SNP in exon 2 and the SJS/TEN susceptibility. In particular, the variant allele (C) resulted significantly associated with a higher risk to develop SJS/TEN (p = 0.012 and OR = 3.65 (95% CI 1.33-10.01)). A multivariate analysis by logistic regression confirmed its significant contribution (p = 0.027, OR = 4.39 (95% CI 1.19-16.23)). In conclusion, our study suggests that a variant in TRAF3IP2 gene could be involved in susceptibility to SJS/TEN.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rs76228616 (G>C)–rs33980500 (G>A) haplotypes distribution in cases and controls. * Each haplotype has been compared vs. the sum of the others. Significant p values are reported in bold.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schröder W., Roujeau J.C., SCAR Study Group Severe cutaneous adverse reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: Results of an international prospective study. Arch. Dermatol. 2002;138:1019–1024. doi: 10.1001/archderm.138.8.1019. - DOI - PubMed
    1. French L.E. Toxic epidermal necrolysis and Stevens Johnson syndrome: Our current understanding. Allergol. Int. 2006;55:9–16. doi: 10.2332/allergolint.55.9. - DOI - PubMed
    1. Schwartz R.A., McDonough P.H., Lee B.W. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J. Am. Acad. Dermatol. 2013;69:187.e1–187.e16. - PubMed
    1. Warren K.J., Boxwell D.E., Kim N.Y., Drolet B.A. Nevirapine-associated Stevens–Johnson syndrome. Lancet. 1998;351:567. doi: 10.1016/S0140-6736(98)24008-6. - DOI - PubMed
    1. Fagot J.P., Mockenhaupt M., Bouwes-Bavinck J.N., Naldi L., Viboud C., Roujeau J.C., EuroSCAR Study Group Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis. AIDS. 2001;15:1843–1848. doi: 10.1097/00002030-200109280-00014. - DOI - PubMed

MeSH terms

Substances